Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA eyes advisory committee overhaul

This article was originally published in The Tan Sheet

Executive Summary

"I think it is time to quietly put together a wholesale review" of the advisory committee program, Acting FDA Commissioner Lester Crawford tells Medical Device Manufacturers Association annual meeting attendees June 10 in response to concerns that the panels are hindering reviews. "This isn't the first time I have thought about" looking at the process, Crawford said, noting the idea has taken on greater significance since FDA recently overruled the panels in all five regulated product areas, such as the decision not to approve the Plan B emergency contraceptive. One continued HHS concern is the number of experts becoming ensconced on panels after serving multiple terms...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS096930

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel